Navigation Links
Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
Date:3/29/2013

HARBIN, China, March 29, 2013 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its results for the year ended December 31, 2012.

Financial Highlights 
 

  • Net revenue was $36.77 million, an increase of 7.5% from full year 2011.
  • Gross profit was $28.03 million, representing a gross margin of 76.2%, an increase of 0.3% from the previous year.
  • Net income was $17.24 million, representing a net margin of 46.9%.
  • Basic and diluted EPS were $1.10 and $1.04, respectively, with 15.45 million basic shares and 16.60 million diluted shares outstanding.

  • Management Commentary

    "While we were quite pleased with our 2012 financial results, as mentioned last quarter, the Company experienced a supply shortage due to required operational maintenance that occurred within our facilities – resulting in full year sales being lower than expected. Despite this short disruption, total sales for the year ended December 31, 2012 grew by 7.5% reaching approximately $36.8 million, as compared to the previous year's sales of $34.2 million. High demand led to a 9.5% year-over-year increase in sales of our core consumer product, Cordyceps; while organic specialty foods sales saw a 4.7% increase and functional health beverages saw a 0.9% increase. Gross profit remained strong at 76.2%. The year of 2012 was also marked by the completion of our large multi-phase, multi-year production capacity expansion project, which overall boosted capacity from 55 tons to 100 tons, a huge milestone achieved for the Company and the team," Ms. Lianyun Han, CEO of Nutrastar, commented.

    On the subject of the Company's finan
    '/>"/>

    SOURCE Nutrastar International Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
    2. International Isotopes Inc. Announces 2012 Year End Financial Results
    3. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
    4. ShangPharma Corporation Announces Completion of Merger
    5. ReSearch Pharmaceutical Services Announces Joint Venture with Asklep in Japan
    6. Convergence Pharmaceuticals Announces Successful Interim Data from Ground-Breaking Phase II Trigeminal Neuralgia Study
    7. CleanPath Resources Corp Announces Worldwide Exclusive Stem Cell Enhancement Agreement with a Division of Hemp, Inc.
    8. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
    9. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
    10. TriReme Announces Signing of a Master Distribution Agreement in China
    11. Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 23, 2015 More than a third of reproductive-aged women ... with private insurance, filled a prescription for an opioid pain ... this week,s Morbidity and Mortality Weekly Report (MMWR). ... treat moderate to severe pain.  They are also found in ...
    (Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ... directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... breached its fiduciary duties to shareholders. On ... investing website reporting that Advaxis had misrepresented the clinical ...
    (Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
    Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
    ... PARSIPPANY, N.J. , July 6 There are more than 374,000 smokers ... die from a smoking-related illness.(1) As of July 1 , they now have ... took effect in all restaurants, bars and workplaces as a result of the Kansas ... Research shows that policy ...
    ... that a new market research report is available in its catalogue: , ... Opportunities in Non-Surgical Bio-Implants: Marketed injectable ... , , ... , Injectable bio-implants ...
    Cached Medicine Technology:Kansas Statewide Smoking Ban May Prompt Smokers to Quit 2Kansas Statewide Smoking Ban May Prompt Smokers to Quit 3Kansas Statewide Smoking Ban May Prompt Smokers to Quit 4Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 2Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 3Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 4Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 5Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 6Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 7Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 8Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 9Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 10Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 11
    (Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
    (Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
    (Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
    (Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
    (Date:1/22/2015)... a new blog post explaining the importance of keeping a first ... an auto insurance policy . , Clients who driver safer ... vehicle insurance policies. The safety a vehicle offers from its driver ... this, drivers should always carry a first aid kit in their ...
    Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
    ... will die from prostate cancer this year. However, a ... combination of androgen suppression therapy (hormone therapy) with radiation ... of androgen, a male sex hormone. Researchers say that ... been shown to improve survival rates for prostate cancer ...
    ... and one of the oldest and most common types ... down and the bones rub against each other causing ... study shows an effective treatment for osteoarthritis is the ... was found to reduces gastric complications that often occur ...
    ... can reduce complications after a blood clot in the ... ,Some of the common complications with deep vein ... swelling, skin discoloration, numbness, chronic pain, hardening of the ... elastic stockings could help patients with blood clots, so ...
    ... public places can improve the overall likelihood someone will ... AEDs -- devices capable of shocking the heart back ... 1,000 shopping malls, apartment complexes, and other public places ... volunteers in these communities were then trained in either ...
    ... affects millions of people worldwide . It is the most ... Alzheimer’s disease are still unknown and there is no cure. ... the key to treating Alzheimer’s disease. A team of researchers ... 37. Some were given sage oil capsules, and some were ...
    ... patients who receive treatment have a greater risk of developing ... are not taking the necessary steps to prevent the clots ... determine if the doctors were aware of the risk of ... physicians. About 40 percent of the doctors who were surveyed ...
    Cached Medicine News: